Table 3 Comparison of patients with Non-diabetic peripheral neuropathy between Mongolian population and Han population

Diabetes duration (month)

102.00 (24.00,156.00)

36.00 (7.50,96.00)

-2.120^b

0.034

Gender (male/female)

15/3

20/14

3.213^c

0.073

Age (years)

49.06 ± 12.27

53.27 ± 10.52

1.296^a

0.201

Smoke (yes/no)

7/11

10/24

0.480^c

0.488

Drink (yes/no)

13/5

12/22

6.429^c

0.011

Waist circumference (cm)

100.00 (94.50,107.25)

92.50 (86.75,96.50)

-3.081^b

0.002

BMI (kg/m²)

28.40 (25.15,29.63)

26.10 (24.85,28.45)

-1.270^b

0.204

MALB (mg/L)

6.85 (2.70,112.28)

5.95 (2.90,43.00)

-0.346^b

0.729

HbA1c (%)

9.10 (8.08,10.20)

8.60 (7.35,9.70)

-0.972^b

0.331

ALT (U/L)

22.00 (14.25,37.75)

24.50 (14.75,36.00)

-0.144^b

0.885

AST (U/L)

21.00 (15.50,29.25)

21.00 (16.75,27.00)

-0.106^b

0.916

GGT (U/L)

29.50 (24.00,53.25)

39.00 (21.50,65.75)

-0.462^b

0.644

FPG (mmol/L)

8.30 (7.20,10.75)

8.04 (6.24,9.56)

-1.222^b

0.222

CREA (umol/L)

62.43 ± 13.99

62.18 ± 15.51

-0.056^a

0.956

UA (umol/L)

350.50 (307.75,412.00)

354.50 (305.00,451.00)

-0.875^b

0.381

CHOL (mmol/L)

4.64 (3.75,5.86)

4.69 (4.02,5.82)

-0.346^b

0.729

TG (mmol/L)

1.65 (1.18,2.25)

1.91 (1.45,2.75)

-0.924^b

0.356

HDL-C (mmol/L)

1.01 (0.89,1.10)

0.99 (0.84,1.12)

-0.318^b

0.751

LDL-C (mmol/L)

2.94 (2.18,3.)

2.76 (2.24,3.44)

-0.029^b

0.977

CNFD (no./mm²)

19.98 ± 4.65

23.56 ± 6.35

2.108^a

0.040

CNBD (no./mm²)

33.12 (23.43,42.96)

36.24 (22.49,51.87)

-0.625^b

0.532

CNFL (mm/mm²)

14.48 ± 3.08

15.74 ± 3.26

1.352^a

0.183